Life expectancy for patients with Parkinson's disease is poorer than some previous studies have suggested, with barely one-third of patients surviving six years with the condition.

Phosphorylated alpha-synuclein, a substance found in the blood of Parkinson's patients, could lead to definitive diagnostic tool. 

Exposure to trichloroethylene (TCE) -- a hazardous organic contaminant found in soil, groundwater, and air -- is significantly associated with increased risk of Parkinson's Disease.

Blocked blood vessels in the brain, that are too small to be seen with current medical imaging technologies, may contribute to declines in walking ability and motor coordination.

People with Parkinson's Disease are at a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases.

U.S. National Institute of Environmental Health Sciences finds that people with diabetes may have a slightly increased risk of developing Parkinson's disease.

A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients.

Caspases, a family of enzymes, play a role in the inflammatory process associated with Alzheimer’s and Parkinson’s Diseases.

Rich in anthocyanins, berries may lower a person’s risk of developing Parkinson’s Disease by up to 40%.

Neuronal exhaustion can lead to premature cell death, potentially triggering the onset of Parkinson’s symptoms.